Retractable Technologies Inc
$ 0.83
1.56%
26 Dec - close price
- Market Cap 24,249,100 USD
- Current Price $ 0.83
- High / Low $ 0.83 / 0.82
- Stock P/E N/A
- Book Value 2.55
- EPS -0.30
- Next Earning Report -
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.09 %
- ROE -0.11 %
- 52 Week High 1.14
- 52 Week Low 0.62
About
Retractable Technologies, Inc. (RVP) is a prominent player in the medical device industry, specializing in the design and manufacture of innovative safety syringes aimed at reducing needle-stick injuries and enhancing patient safety. Headquartered in Little Elm, Texas, the company serves a broad client base domestically and internationally, positioning itself as an essential partner in healthcare. With a steadfast commitment to innovation and quality, Retractable Technologies is well-positioned for future growth as it seeks to expand its product portfolio and fortify its global market presence.
Analyst Target Price
N/A
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-11-14 | 2025-08-14 | 2025-05-13 | 2025-03-27 | 2024-11-12 | 2024-08-14 | 2024-05-15 | 2024-03-29 | 2023-11-14 | 2023-08-14 | 2023-05-15 | 2023-03-30 |
| Reported EPS | 0.01 | -0.0048 | -0.3527 | 0.124 | -0.0661 | -0.4751 | 0.0124 | -0.0044 | -0.1376 | -0.1302 | -0.145 | -0.13 |
| Estimated EPS | None | 0 | None | None | None | None | None | None | None | None | None | None |
| Surprise | 0 | -0.0048 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Surprise Percentage | None% | None% | None% | None% | None% | None% | None% | None% | None% | None% | None% | None% |
Next Quarterly Earnings
| Reported Date |
| Fiscal Date Ending |
| Estimated EPS |
| Currency |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: RVP
2025-12-06 16:09:37
This article analyzes RVP's stock performance following its Q3 earnings report. Despite facing challenges from tariffs and rising costs, the company's stock has shown an increase, suggesting investor confidence in its financial results or outlook.
2025-12-06 16:09:37
The global smart syringes market is projected to reach $2.22 billion by 2033, growing at an 8.7% CAGR from 2025, driven by increased safety focus and rising cases of Needle Stick Injuries (NSIs). Government-led immunization programs, especially in developing nations, and regulatory mandates for safety-engineered injection devices are significantly boosting the demand for auto-disable smart syringes to prevent blood-borne infections and enhance vaccine safety. Key players in this market include Becton, Dickinson and Company, Terumo Corporation, and Gerresheimer AG, among others, with market segmentation covering product types, applications, distribution channels, and technologies.
2025-12-04 14:08:44
The global smart syringes market is projected to reach $2.22 billion by 2033, growing at a CAGR of 8.7% from 2025, driven by the critical need to improve patient and healthcare worker safety. This growth is largely fueled by the rising incidence of Needle Stick Injuries (NSIs) and blood-borne infections, coupled with government-led immunization programs. Regulatory mandates in the U.S. and Europe for safety-engineered injection devices are further accelerating the adoption of smart syringes, particularly auto-disable types, to prevent reuse and enhance vaccine safety in developing nations.
2025-11-20 14:08:57
Retractable Technologies, Inc. (RVP) saw its stock rise by 1.5% after reporting its Q3 2025 earnings, outperforming the S&P 500. Despite a decrease in net sales to $10.1 million, the company improved its gross profit to $1.7 million, largely due to lower manufacturing costs and a favorable product mix, resulting in a net income of $0.4 million compared to a prior-year loss. The company continues to navigate significant tariff costs and implement strategic shifts towards domestic production to mitigate these ongoing pressures.
2025-11-17 04:50:58
Retractable Technologies, Inc. (NYSE American: RVP) reported third-quarter 2025 net sales of $10.1 million and an operating loss of $3.7 million. For the first nine months of 2025, net sales were $28.8 million, with 38.3% of products manufactured in the U.S., a significant increase from 10% in 2024, as the company works to mitigate the impact of tariffs. The company also reported a net income of $371 thousand for Q3, including unrealized gains on investments.
2025-11-17 04:50:58
Retractable Technologies, Inc. (NYSE American: RVP) has received an Innovative Technology designation from Vizient for its EasyPoint Blood Collection Tube Holder with Needle. This recognition highlights the product's potential to enhance clinical care, patient safety, and healthcare worker safety by effectively reducing the risk of needlestick injuries and improving workflow efficiency. The EasyPoint device features automated retraction, a pre-attached needle, and an integrated low-profile safety mechanism to ensure optimal safety and ease of use.
